Back

Prevalence of cardiac amyloidosis among cardiac- and non-cardiac patients undergoing echocardiography at a large university echo lab in Germany: a cohort study

27 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: National registries for rare myocardial diseases Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Richard B Albrecht

University hospital Jena, Jena (Germany)

7 More presentations in this session

Presentation thumbnail
Trends in the prevalence of infiltrative cardiomyopathy among patients with in-hospital cardiac arrest- insight from the US national inpatient sample database
Doctor S. Nandy (Bronx, US)
Abstract Slides
Presentation thumbnail
HCM-AF South Italy score for prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy: data from a derivation and validation italian cohorts.
Doctor G. Todde (Naples, IT)
Abstract Slides
Presentation thumbnail
Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany
Doctor M. Tome Esteban (London, GB)
Abstract Slides
Presentation thumbnail
Evaluating risk factors, biomarkers and management of myocarditis following treatment with checkpoint inhibitors. A retrospective analysis.
Doctor M. Abdimalik (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Genetic and clinical characteristics of transthyretin cardiac amyloidosis in Koreans
Doctor K. Jeon (Seoul, KR)
Abstract Slides

Access the full session

Session thumbnail
National registries for rare myocardial diseases

The Event

Event poster

ESC Congress 2022

27 August 2022 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources